Sort
85,873 grants matching “alzheimers”
Forward Genetic Analysis of Innate Immune Signaling
$875,418Bruce A Beutler · Scripps Research Institute, The · U19 · FY2015 · AI
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)
$875,377Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2020 · AG
Skipping the hospital: acute hospital care at home for people living with dementia
$875,176David Michael Levine · Brigham And Women'S Hospital · R01 · FY2025 · AG
Novel, Orally-Available Prodrugs for Alzheimer's Disease
$875,154Francis X Tavares · Resilio Therapeutics, Llc · R44 · FY2018 · AG
Structural Biology Core
$875,099Karson Putt · Indiana University Indianapolis · U54 · FY2022 · AG
Creating adaptive, wearable technologies to assess and intervene for individuals with ADRDs
$875,002Diane Joyce Cook · Washington State University · R35 · FY2023 · AG
Florida Alzheimer's Disease Research
$875,000Huntington Potter · University Of South Florida · P50 · FY2010 · AG
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias
$874,857Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2025 · AG
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$874,802Andrew J Saykin · Indiana University Indianapolis · U01 · FY2025 · AG
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias
$874,542Wei-Qi Wei · Vanderbilt University Medical Center · R56 · FY2024 · AG
Prediction of Cognitive Decline with MRI and MRS
$874,540Northern California Institute Res &Educ · R01 · FY2004 · AG
Fluorescent IRE sensor for synucleinopathy drug discovery
$874,414Wen Shen · Lucerna, Inc. · R44 · FY2023 · NS
Mild Cognitive Impairment: Cerebrovascular Dysfunction and Exercise Training
$874,381Rong Zhang · Ut Southwestern Medical Center · R01 · FY2011 · AG
PRO: A Protein Ontology in OBO Foundry for Integration of Biomedical Knowledge
$874,165Cathy H Wu · University Of Delaware · R01 · FY2014 · GM
AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline
$874,146Edward R Marcantonio · Beth Israel Deaconess Medical Center · R01 · FY2023 · AG
Apoptosis In Neurodegenerative Disorders
$874,144Mark Mattson · National Institute On Aging · ZIA · FY2017 · AG
Long Life Family Study: Columbia University
$874,131Stephanie Ann Cosentino · Columbia University Health Sciences · U01 · FY2017 · AG
Project 3 - Animal Models Examining Neurovasculature
$874,035Marcelo Pablo Coba · University Of Southern California · P01 · FY2023 · AG
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$874,009Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2023 · AG
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging
$874,000Sarah Renee Ocanas · Oklahoma Medical Research Foundation · DP5 · FY2025 · OD
Clinical Core
$873,729James McCallum Noble · Columbia University Health Sciences · P30 · FY2022 · AG
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
$873,715Dan Vlad Iosifescu · New York University School Of Medicine · R01 · FY2020 · AG
Prediction of Cognitive Decline with MRI and MRS
$873,703Michael W Weiner · Northern California Institute/Res/Edu · R01 · FY2006 · AG
Palliative Care for Persons with Late-stage Alzheimer's and Related Dementias and their Caregivers: a Randomized Clinical Trial
$873,307Laura C Hanson · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease
$873,295Michael D Fox · Brigham And Women'S Hospital · R56 · FY2021 · AG